We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Telephone and Data Systems
TDS
$3.73B
| $920K | ﹤0.01% |
33,149
-12,044
| -27% | -$331K |
|
1702
Sabra Healthcare REIT
SBRA
$5.37B
| $919K | ﹤0.01% |
38,124
+295
| +0.8% | +$7.5K |
|
|
PCH
1703
DELISTED
PotlatchDeltic
PCH
| $916K | ﹤0.01% |
20,048
+135
| +0.7% | +$6.21K |
|
1704
Valvoline
VVV
$4.52B
| $915K | ﹤0.01% |
+38,564
| New | +$893K |
|
1705
Gray Television
GTN
$529M
| $911K | ﹤0.01% |
+66,509
| New | +$898K |
|
1706
Kimco Realty
KIM
$16.6B
| $911K | ﹤0.01% |
49,634
-51,535
| -51% | -$1.01M |
|
|
IMGN
1707
DELISTED
Immunogen Inc
IMGN
| $905K | ﹤0.01% |
+127,274
| New | +$582K |
|
|
SPNC
1708
DELISTED
Spectranetics Corp
SPNC
| $898K | ﹤0.01% |
23,398
+2,611
| +13% | +$75.3K |
|
|
NGHC
1709
DELISTED
National General Holdings Corp
NGHC
| $894K | ﹤0.01% |
42,362
+11,888
| +39% | +$262K |
|
1710
Bio-Techne
TECH
$11.3B
| $888K | ﹤0.01% |
30,224
-608
| -2% | -$16.6K |
|
1711
Center Bancorp
CNOB
$1.78B
| $887K | ﹤0.01% |
39,322
+9,354
| +31% | +$213K |
|
1712
ESCO Technologies
ESE
$7.87B
| $886K | ﹤0.01% |
14,847
-5,135
| -26% | -$299K |
|
1713
SITE Centers
SITC
$166M
| $884K | ﹤0.01% |
75,649
+11,092
| +17% | +$145K |
|
|
CMD
1714
DELISTED
Cantel Medical Corporation
CMD
| $880K | ﹤0.01% |
11,294
-9,560
| -46% | -$718K |
|
|
WMGI
1715
DELISTED
Wright Medical Group Inc
WMGI
| $880K | ﹤0.01% |
32,018
+19,164
| +149% | +$542K |
|
1716
Cavco Industries
CVCO
$4.55B
| $878K | ﹤0.01% |
6,770
-10,814
| -61% | -$1.29M |
|
|
UNIT
1717
Uniti Group
UNIT
$2.31B
| $871K | ﹤0.01% |
34,636
+381
| +1% | +$9.87K |
|
|
MSFG
1718
DELISTED
MainSource Financial Group Inc
MSFG
| $870K | ﹤0.01% |
25,950
+1,975
| +8% | +$65.4K |
|
1719
Mistras Group
MG
$501M
| $869K | ﹤0.01% |
39,560
-77,728
| -66% | -$1.67M |
|
|
FCE.A
1720
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $869K | ﹤0.01% |
35,976
+104
| +0.3% | +$2.4K |
|
1721
W.P. Carey
WPC
$16.4B
| $868K | ﹤0.01% |
13,428
-7,375
| -35% | -$466K |
|
|
FRGI
1722
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $866K | ﹤0.01% |
+41,936
| New | +$951K |
|
1723
Evolent Health
EVH
$456M
| $862K | ﹤0.01% |
34,004
+360
| +1% | +$8.66K |
|
1724
Artivion
AORT
$1.35B
| $860K | ﹤0.01% |
43,103
+4,090
| +10% | +$73.3K |
|
|
KRA
1725
DELISTED
Kraton Corporation
KRA
| $860K | ﹤0.01% |
24,977
-158,127
| -86% | -$5.18M |
|
Similar funds
VGA
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.